Geneos Wealth Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Geneos Wealth Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,500	Closed	-$38K	–	2648
2022 Q2	$38K	Hold	2,500	–	–	﹤0.01%	1400
2022 Q1	$50K	Hold	2,500	–	–	﹤0.01%	1388
2021 Q4	$72K	Hold	2,500	–	–	﹤0.01%	1312
2021 Q3	$52K	Hold	2,500	–	–	﹤0.01%	1482
2021 Q2	$65K	Hold	2,500	–	–	﹤0.01%	1361
2021 Q1	$53K	Hold	2,500	–	–	﹤0.01%	1604
2020 Q4	$45K	Sell	2,500 -146	-6%	-$1.33K	﹤0.01%	1506
2020 Q3	$19K	Hold	2,646	–	–	﹤0.01%	1686
2020 Q2	$15K	Hold	2,646	–	–	﹤0.01%	1758
2020 Q1	$12K	Hold	2,646	–	–	﹤0.01%	1752
2019 Q4	$21K	Hold	2,646	–	–	﹤0.01%	1676
2019 Q3	$13K	Hold	2,646	–	–	﹤0.01%	1799
2019 Q2	$14K	Hold	2,646	–	–	﹤0.01%	1794
2019 Q1	$11K	Hold	2,646	–	–	﹤0.01%	1818
2018 Q4	$10K	Hold	2,646	–	–	﹤0.01%	1801
2018 Q3	$18K	Hold	2,646	–	–	﹤0.01%	1637
2018 Q2	$10K	Hold	2,646	–	–	﹤0.01%	1741
2018 Q1	$7K	Buy	+2,646	New	+$8.17K	﹤0.01%	1789

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geneos Wealth Management's CDMO Position: Q3 2022 in Review

Geneos Wealth Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2022, closing a stake of 2,500 shares — an estimated $38K sold.

Geneos Wealth Management first reported a position in CDMO in Q1 2018 and held it in 18 quarters. The position peaked at $72K in Q4 2021. 184 funds tracked by Wall St. Rank hold CDMO as of Q3 2022.

Geneos Wealth Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 2,500 Avid Bioservices, Inc. Common Stock shares in Q3 2022, an estimated $38K.
Geneos Wealth Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2018 and held it in 18 quarters.
Geneos Wealth Management's Avid Bioservices, Inc. Common Stock position peaked at $72K in Q4 2021.
184 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.